Holyday 2012.

Methods	Randomised clinical trial, Australia
Participants	143 hospitalised adults admitted to the geriatric ward due to falls, delirium and polypharmacy problems, at nutritional risk due to being elderly frail Male:Female = 61:82 Mean age = 83.5 Exclusion criteria: expected length of stay < 72 hrs, palliative unable to be nutritionally assessed (non‐English‐speaking, severe dementia/confusion, non‐co‐operative/refused), already seen by a dietitian during the admission (e.g. transferred from another ward) or enrolled in the study during a previous admission
Interventions	Experimental group: General nutrition support. The Malnutrition Care Plan involved the modification of hospital meals (texture modification and fortification), prescription of nutrition supplements, i.e. nutrient‐dense drinks and snacks including commercial supplements, flagging for assistance with meals by ward‐based staff, education of participants and their caregivers regarding optimisation of nutrition intake and referral to other health professionals for discharge planning. The Malnutrition Care Plan was tailored to individual requirements based on the clinical dietitian’s assessment and prescription.(n = 71) Control group: Treatment as usual(n = 72)
Outcomes	Weight, mortality, length of stay and cost of hospital admission
Study dates	Between April 2006 and September 2006
Notes	We contacted the authors on 9th June 2015 by email: Margaret.Holyday@sesiahs.health.nsw.gov.au. We received no reply.
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Low risk	Participants were randomised by computerised random‐number generator.
Allocation concealment (selection bias)	Unclear risk	Not described
Blinding of participants and personnel (performance bias) All outcomes	High risk	Participants and personnel could not be blinded.
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Not described
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	The number of participants with incomplete data was not reported.
Selective reporting (reporting bias)	Unclear risk	No protocol could be obtained and the trial did not report serious adverse events.
For‐profit bias	High risk	The trial was funded by the Gut Foundation (Randwick, Australia) and funded by Pharmatel Fresenius Kabi Pty Ltd.
Other bias	Low risk	The trial appeared to be free of other components that could put it at risk of bias.